Neuroscience
Parkinson's Disease
100%
Diabetes
88%
Dyskinesia
59%
L-DOPA
59%
Neuron
37%
Diabetes Mellitus
35%
Ropinirole
29%
Stroke
29%
Denervation
29%
Glimepiride
21%
Dopaminergic
15%
Blood Brain Barrier
14%
Neurodegenerative Disorder
14%
Middle Cerebral Artery
8%
Microglia
7%
Dopaminergic Neuron
7%
Striatum
7%
Interneuron
5%
Parvalbumin
5%
Glucagon-Like Peptide-1 Agonist
5%
Immunohistochemistry
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
64%
Vascular Disease
43%
Lipid Diet
41%
Male
32%
Diabetes
29%
Dipeptidyl Peptidase-4 Inhibitor
29%
Apoplexy
29%
Capillary
29%
Sulfonylurea
29%
Brain
21%
Glimepiride
21%
Disease
19%
Antidiabetic Agent
12%
Microvessel
12%
Pathology
12%
Degenerative Disease
9%
Glucagon Like Peptide 1 Receptor
8%
Middle Cerebral Artery Occlusion
8%
Lesion
8%
Striatum
6%
Insulin Sensitivity
5%
Atrophy
5%
Vascular Remodeling
5%
Scar Formation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Levodopa-Induced Dyskinesia
59%
DOPA
54%
Rat Model
35%
Non Insulin Dependent Diabetes Mellitus
29%
Ropinirole
29%
Exendin 4
29%
Dopamine Receptor Stimulating Agent
29%
Parkinson's Disease
20%
Amphetamine
17%
Dopamine
16%
Vascular Remodeling
5%
Glucagon Like Peptide 1 Receptor Agonist
5%
Preclinical Study
5%